Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2021.08.18

Sai Life Sciences opens new Discovery Biology facility at its integrated R&D campus in Hyderabad, India

Biology facility, Hyderabad

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO-CDMO), today announced the opening of a new biology facility at its integrated R&D campus in Hyderabad, India. The facility marks an important milestone in the journey of positioning itself as a differentiated player in Discovery Biology.

Making the announcement, CEO & Managing Director of Sai Life Sciences, Krishna Kanumuri said, “The new facility marks the culmination of a journey we began two years ago, of creating differentiated value for our discovery clients through an integrated delivery model across Boston and Hyderabad. By bringing the best of talent, technology, complementary services and efficiency we are confident of bringing unique value to our clients and are keen to take on integrated discovery mandates, at scale.”

Continuing with the company’s aggressive growth in its biology services, the new state-of-the-art facility houses expanded in vitro and in vivo biology services, DMPK, toxicology and a vivarium. In this new facility Sai Life Sciences is augmenting both, its capabilities and capacity, to deploy cutting-edge platforms and technologies for accelerating integrated drug discovery programs.

Boston-Hyderabad integrated delivery model

Sai Life Sciences has been steadily growing its biology capabilities to complement its strong foundation in medicinal chemistry, DMPK and toxicology for supporting its customers across the entire drug discovery journey from target ID and validation to IND. In 2019, the company opened its first international R&D facility with a biology lab in Boston, USA. The Boston Biology Lab is designed to offer start-up and biotech companies in the region biology services to address exploratory and custom biology needs.

The company’s integrated delivery model for Biology aims to provide its clients an optimal solution in terms of expertise, speed, and cost. In this model, critical exploratory work involving close hand-in-hand collaboration with clients is done at the Boston lab, following which, established assays are tech transferred to Hyderabad for greater throughput. A seamless and rapid technology transfer across sites is achieved through a unified global organization and matching infrastructure across both sites. Encouraged by the initial success with the Boston-Hyderabad integrated model, the company plans to expand its capacity at both locations in the coming months.

The company’s discovery services support a wide range of global innovator companies from start-ups to large pharma companies, across a diverse set of therapeutic areas including oncology, CNS, antivirals, and inflammation among others. With a strong track record of enduring customer relationships averaging 10+ years, Sai Life Sciences has advanced 35+ programs to different clinical phases (IND to Phase-III) with the average turnaround time from Hit/Lead to Candidate being 18 months.

The opening of the new biology block in Hyderabad culminates the company’s journey of unifying its discovery, early & late phase development and clinical supply capabilities in a single 13-acre campus housing over 1000 scientists, delivering integrated value at scale.

Share article

News

2021.09.14

Sai Life Sciences achieves EcoVadis Silver for Sustainability

Sai Life Sciences achieves EcoVadis Silver for Sustainability

In a global assessment acknowledged as a gold standard by procurers and suppliers, winning a silver is gratifying. With a net score of 57, nine points higher than last year, Sai Life Sciences has reaffirmed its commitment to social, economic and environmental responsibility in the evaluation by EcoVadis, the world’s most trusted provider of business […]
Read more

2021.09.02

Sai Life Sciences’ API Manufacturing unit receives ‘CII Excellent Energy Efficient Unit’ award

Sai Life Sciences’ API Manufacturing unit receives ‘CII Excellent Energy Efficient Unit’ award

Sai Life Sciences, a global CRO & CDMO offering sustainable solutions to pharmaceutical companies through strategic partnerships and integrated drug discovery and development services, has been awarded with ‘Excellent Energy Efficient Unit’ in the general category at CII’s 22nd National Energy Management Awards. This is the second consecutive year that Sai Life Sciences’ Bidar API […]
Read more

2021.09.01

GSK Environmental Sustainability Supplier Award 2021

Sai Life Sciences wins GSK’s Environmental Sustainability Supplier award 2021 in the ‘Primary Manufacturing’ category

Every year, GlaxoSmithKline (GSK) organises the Environmental Supplier awards to recognise its suppliers’ contribution to environmental sustainability. Now in its 8th year, the platform has grown to become a prestigious forum for recognising superior environmental sustainability practices across the company’s global value chain, with growing participation from several of its direct and indirect suppliers. At […]
Read more

2021.08.26

Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)

Sai Life Sciences becomes a signatory of the United Nations Global Compact (UNGC)

Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), today announced that it has become a signatory of the United Nations Global Compact (UNGC), the world’s largest sustainability initiative. As a signatory, Sai Life Sciences has committed itself to adopting the Ten Principles of the UNGC on human rights, labour, […]
Read more

2021.08.20

Sai Life Sciences wins Gold at the Brandon Hall Group Excellence Awards 2021

Sai Life Sciences wins Gold at the Brandon Hall Group Excellence Awards 2021

Sai Life Sciences won the Gold Award in Brandon Hall Group Excellence Awards under the “Best Advance in Learning Technology Implementation” category. Standing tall amongst leading global companies like Pfizer, Abbvie, Boehringer, Merck, Takeda, and others, Sai Life Sciences was honored with this award for its consistent innovation in developing the industry’s best learning management […]
Read more